Evidence map›Paper›PMID 34322286›Full record

ArticleAmerican journal of blood research2021

Graves' disease patients with iron deficiency anemia: serologic evidence of co-existent autoimmune gastritis.

Andrew G Gianoukakis, Shelly Gupta, Theresa N Tran, Patrick Richards, Marelle Yehuda, Sarah E Tomassetti

Open access · greenAbstract read
In one paragraph

Article in American journal of blood research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Andrew G GianoukakisDivision of Endocrinology and Metabolism, Division of Hematology and Oncology, Harbor-UCLA Medical Center and The David Geffen School of Medicine at UCLA Los Angeles, CA, USA.
Shelly GuptaDivision of Endocrinology and Metabolism, Division of Hematology and Oncology, Harbor-UCLA Medical Center and The David Geffen School of Medicine at UCLA Los Angeles, CA, USA.
Theresa N TranDivision of Endocrinology and Metabolism, Division of Hematology and Oncology, Harbor-UCLA Medical Center and The David Geffen School of Medicine at UCLA Los Angeles, CA, USA.
Patrick RichardsDivision of Endocrinology and Metabolism, Division of Hematology and Oncology, Harbor-UCLA Medical Center and The David Geffen School of Medicine at UCLA Los Angeles, CA, USA.
Marelle YehudaDivision of Endocrinology and Metabolism, Division of Hematology and Oncology, Harbor-UCLA Medical Center and The David Geffen School of Medicine at UCLA Los Angeles, CA, USA.
Sarah E TomassettiDivision of Endocrinology and Metabolism, Division of Hematology and Oncology, Harbor-UCLA Medical Center and The David Geffen School of Medicine at UCLA Los Angeles, CA, USA.
UCLA Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGraves' disease (GD) has been associated with iron deficiency anemia (IDA). Atrophic gastritis leads to IDA and has been associated with autoimmune thyroid disease. This study prospectively determined the prevalence of atrophic gastritis markers and the relationship between these markers and markers of IDA in GD subjects.

methodsNewly diagnosed GD patients (90) and controls (41) were studied. Of the newly diagnosed GD patients, 65 were consecutively enrolled and identified with GD irrespective of anemia, 25 had GD and IDA. Thyroid function, hematologic indices, and atrophic gastritis markers [parietal-cell antibodies (PCab),

resultsGD patients presenting with IDA were twice as likely (64% vs. 32%, P=0.049) to harbor PCabs when compared to all other GD subjects. Unselected GD subjects (n=65) had significantly higher PCab (37% vs. 7%, P<0.001) compared to controls. Gastrin levels were significantly elevated in all GD subjects compared to controls (105 vs. 39 pg/ml, P<0.0001). This difference was magnified in PCab+ subjects (202 vs. 64 pg/ml, P=0.003). In all GD subjects, PCabs were associated with increased gastrin levels (202 vs. 75 pg/ml, P=0.0004) and lower ferritin levels (52 vs. 95, P=0.05). In GD anemic subjects, PCabs were associated with lower mean corpuscular volume (75 vs. 81, P=0.001). Gastrin levels correlated inversely with ferritin levels in all GD subjects and positively with TIBC in GD anemic subjects.

conclusionsA significant subset of patients presenting with GD may suffer from IDA due to concurrent autoimmune atrophic gastritis.

Indexed as

atrophic gastritisautoimmuneGraves’ diseaseiron deficiency anemiaIron metabolism

Identifiers

PMID34322286
PMCPMC8303011
OpenAlexW3185478083

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.